|
KIF20B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.77958999999506E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.483850E-02 |
| Normal-vs-Stage2 |
4.013600E-01 |
| Normal-vs-Stage3 |
7.561000E-04 |
| Normal-vs-Stage4 |
3.086500E-02 |
| Stage1-vs-Stage2 |
7.083200E-01 |
| Stage1-vs-Stage3 |
7.655300E-03 |
| Stage1-vs-Stage4 |
1.088960E-01 |
| Stage2-vs-Stage3 |
3.360000E-02 |
| Stage2-vs-Stage4 |
9.227600E-02 |
| Stage3-vs-Stage4 |
8.784800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.403930E-04 |
| Normal-vs-AfricanAmerican |
3.621800E-02 |
| Normal-vs-Asian |
7.945800E-02 |
| Caucasian-vs-AfricanAmerican |
5.776200E-01 |
| Caucasian-vs-Asian |
2.809600E-01 |
| AfricanAmerican-vs-Asian |
1.809240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.062700E-03 |
| Normal-vs-Female |
1.41519999996564E-06 |
| Male-vs-Female |
8.785400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.171800E-02 |
| Normal-vs-Extreme_Weight |
1.716810E-01 |
| Normal-vs-Obese |
3.570800E-04 |
| Normal-vs-Extreme_Obese |
7.313400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.964600E-01 |
| Normal_Weight-vs-Obese |
1.554810E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.131000E-01 |
| Extreme_Weight-vs-Obese |
1.373900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.050800E-01 |
| Obese-vs-Extreme_Obese |
1.157560E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.620950E-03 |
| Normal-vs-Age(41-60Yrs) |
2.50589999994943E-06 |
| Normal-vs-Age(61-80Yrs) |
6.220000E-02 |
| Normal-vs-Age(81-100Yrs) |
8.235800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.355990E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.585400E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.598500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.206370E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.913700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.840200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.224900E-03 |
| Normal-VS-Type2 PRCC |
2.323600E-01 |
| Normal-VS-KIRP CIMP |
1.120400E-03 |
| Normal-VS-Unclassified PRCC |
1.659160E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.302000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.661200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.063500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.564450E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.586120E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.038900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.044370E-01 |
| Normal-vs-N1 |
6.36210000000137E-05 |
| Normal-vs-N2 |
3.411600E-01 |
| N0-vs-N1 |
9.767600E-04 |
| N0-vs-N2 |
3.802600E-01 |
| N1-vs-N2 |
3.649200E-01 |
|
|
